ORGO Klasse A Organogenesis Holdings Inc. - Class A
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$1,33
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$1,3252-Wochen-Tief
$7,0852-Wochen-Hoch
Marktkapitalisierung (MRQ)
$171M
P/E (TTM)
-1.7
EPS (TTM)
$-0.79
Umsatz (TTM)
$457M
Ihre Abzeichen
52W-Spanne
$1–$7
Analystenbewertung
HOLD
Kursziel
$2
P/E
-1.7
ROE
-44.1%
Nettogewinnmarge
-18.4%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ORGO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$1.33
Marktkapitalisierung (MRQ)
$171M
P/E (TTM)
-1.7
EPS (TTM)
$-0.79
Umsatz (TTM)
$457M
ROE (TTM)
-44.1%
52W-Spanne
$1–$7
ORGO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$564M2016-12-31 → 2025-12-31
EPS$0.152018-12-31 → 2025-12-31
Freier Cashflow$-24M2022-12-31 → 2025-12-31
Nettogewinnmarge-18.4%2022-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ORGO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -1.75-Jahres-Durchschnitt ≈-29.5 | ≈-29.5 | · | · | |
| P/S (TTM) | 0.45-Jahres-Durchschnitt ≈1.1 | ≈1.1 | 6.4 | Unterbewertet | |
| K/B (MRQ) | 1.25-Jahres-Durchschnitt ≈1.8 | ≈1.8 | 1.9 | Überbewertet | |
| Kurs / FCF (TTM) | 8.25-Jahres-Durchschnitt ≈5.4 | ≈5.4 | · | · | |
| Kurs / Cashflow (TTM) | 5.45-Jahres-Durchschnitt ≈-10.8 | ≈-10.8 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 1.25-Jahres-Durchschnitt ≈2.9 | ≈2.9 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ORGO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -7.8%5-Jahres-Durchschnitt ≈5.3% | ≈5.3% | -833.9% | Spitzenklasse | |
| EBITDA-Marge (TTM) | -4.4%5-Jahres-Durchschnitt ≈6.2% | ≈6.2% | -475.2% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | -7.6%5-Jahres-Durchschnitt ≈5.1% | ≈5.1% | -1646.3% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | -18.4%5-Jahres-Durchschnitt ≈3.7% | ≈3.7% | -1223.2% | Spitzenklasse | |
| ROA (TTM) | -19.4%5-Jahres-Durchschnitt ≈3.8% | ≈3.8% | -34.3% | Spitzenklasse | |
| ROE (TTM) | -44.1%5-Jahres-Durchschnitt ≈7.2% | ≈7.2% | -39.3% | Spitzenklasse | |
| ROIC | 11.7%5-Jahres-Durchschnitt ≈6.8% | ≈6.8% | -44.2% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ORGO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 3.55-Jahres-Durchschnitt ≈3.1 | ≈3.1 | 8.6 | Geringe Liquidität | |
| Quick Ratio | 3.15-Jahres-Durchschnitt ≈2.7 | ≈2.7 | 7.8 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | ORGO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 17.0%5-Jahres-Durchschnitt ≈11.8% | ≈11.8% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 7.8%5-Jahres-Durchschnitt ≈5.8% | ≈5.8% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 10.8% | · | · | · | |
| EPS YoY (EPS VjV) | -66.7%5-Jahres-Durchschnitt ≈72.4% | ≈72.4% | · | · | |
| Net Income YoY (Nettogewinn YoY) | 4201.1%5-Jahres-Durchschnitt ≈882.7% | ≈882.7% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | 7.7% | · | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | 0.00% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | 33.6%5-Jahres-Durchschnitt ≈-26.5% | ≈-26.5% | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | 16.5% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | ORGO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 1.05-Jahres-Durchschnitt ≈1.0 | ≈1.0 | 0.0 | Spitzenklasse | |
| Receivables Turnover (Forderungsumschlag) | 3.45-Jahres-Durchschnitt ≈4.6 | ≈4.6 | 22.2 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$660.6K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-11.3%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 6, 2026 | $-0.73 | $-0.36 | -104.5% |
| 31. März 2026 | Mai 7, 2026 | $-0.41 | $-0.32 | -29.7% |
| 31. Dezember 2025 | $0.31 | $0.21 | 44.7% | |
| 30. September 2025 | $0.15 | $0.06 | 167.4% | |
| 30. Juni 2025 | $-0.10 | $-0.06 | -73.0% | |
| 31. März 2025 | $-0.10 | $-0.06 | -73.0% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $564M | $482M | $433M | $451M | $467M | $338M | $261M | $193M | $199M | $139M | |
| Cost of Revenue | · | $116M | $106M | $105M | $114M | $87M | $76M | $69M | $61M | $48M | |
| Gross Profit | · | $366M | $327M | $346M | $353M | $251M | $185M | $125M | $137M | $91M | |
| R&D Expense | $45M | $50M | $44M | $40M | $31M | $20M | $15M | $11M | $9M | $6M | |
| SG&A Expense | $326M | $295M | $270M | $284M | $250M | $204M | $200M | $162M | $134M | $93M | |
| Operating Expenses | $519M | $483M | $421M | $324M | $281M | $224M | $215M | $176M | $143M | $99M | |
| Operating Income | $45M | $-1M | $13M | $22M | $72M | $27M | $-30M | $-52M | $-5M | $-9M | |
| Interest Expense | · | · | $2M | $2M | $7M | $11M | $9M | $11M | $8M | $6M | |
| Interest Income | · | · | · | · | · | · | · | $64.0K | $129.0K | $153.0K | |
| Other Non-op | $-5.0K | $20.0K | $57.0K | $-13.0K | $-13.0K | $97.0K | $13.0K | $162.0K | $-9.0K | $285.0K | |
| Pretax Income | $47M | $-3M | $10M | $20M | $63M | $18M | $-39M | $-65M | $-15M | $-15M | |
| Income Tax | $10M | $-4M | $5M | $5M | $-31M | $530.0K | $150.0K | $84.0K | $-7M | $65.0K | |
| Net Income | $37M | $861.0K | $5M | $16M | $94M | $17M | $-39M | $-65M | $-8M | $-17M | |
| EPS (Basic) | $0.16 | $-0.01 | $0.04 | $0.12 | $0.73 | $0.16 | $-0.42 | $-0.94 | · | · | |
| EPS (Diluted) | $0.15 | $-0.01 | $0.04 | $0.12 | $0.70 | $0.15 | $-0.42 | $-0.94 | · | · | |
| Shares (Basic) | 126,738,136 | 131,673,278 | 131,231,317 | 130,070,231 | 128,331,022 | 107,737,936 | 92,840,401 | 69,318,456 | · | · | |
| Shares (Diluted) | 130,248,412 | 131,673,278 | 132,746,727 | 132,383,152 | 133,662,659 | 111,360,831 | 92,840,401 | 69,318,456 | · | · | |
| EBITDA | $60M | · | $13M | $22M | · | · | · | · | · | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $94M | $136M | $104M | $102M | $114M | $84M | $60M | $21M | $2M | $1M | |
| Receivables | $217M | $110M | $82M | $89M | $82M | $57M | $39M | $34M | $28M | · | |
| Inventory | $30M | $26M | $28M | $25M | $25M | $28M | $23M | $13M | $14M | · | |
| Prepaid Expense | $18M | $14M | $10M | $5M | $5M | $5M | $3M | $2M | $4M | $395.8K | |
| Current Assets | $362M | $286M | $225M | $223M | $227M | $174M | $126M | $71M | $50M | $1M | |
| PP&E (Net) | $104M | $89M | $116M | $102M | $79M | $56M | $47M | $40M | $42M | · | |
| PP&E (Gross) | $165M | $140M | $130M | $100M | $89M | $88M | $83M | $79M | $79M | · | |
| Accum. Depreciation | $88M | $73M | $73M | $63M | $58M | $74M | $66M | $62M | $59M | · | |
| Goodwill | $29M | $29M | $29M | $29M | $29M | $29M | $26M | $26M | $26M | · | |
| Intangibles | $9M | $12M | $16M | $21M | $26M | $31M | $21M | $26M | $30M | · | |
| Other Non-current Assets | $9M | $5M | $6M | $2M | $2M | $670.0K | $884.0K | $579.0K | $735.0K | · | |
| Total Assets | $599M | $498M | $460M | $449M | $443M | $290M | $221M | $164M | $149M | $311M | |
| Accounts Payable | $32M | $29M | $31M | $32M | $29M | $23M | $28M | $19M | $19M | · | |
| Accrued Liabilities | $50M | $39M | $30M | $26M | $37M | $24M | $23M | $20M | $23M | $50.8K | |
| Short-term Debt | · | · | · | · | · | · | $0 | $3M | $0 | · | |
| Current Liabilities | $100M | $77M | $81M | $75M | $83M | $68M | $60M | $56M | $52M | $478.4K | |
| Capital Leases | $22M | $25M | $25M | $21M | $47M | $0 | $14M | $15M | $12M | · | |
| Other Non-current Liabilities | $1M | $894.0K | $1M | $1M | $2M | $8M | $7M | $6M | $2M | · | |
| Total Liabilities | $165M | $113M | $181M | $184M | $202M | $148M | $165M | $117M | $157M | $11M | |
| Long-term Debt | · | · | $67M | $71M | $74M | $70M | · | · | $52M | · | |
| Common Stock | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $10.0K | $9.0K | $6.0K | · | |
| Paid-in Capital | · | · | · | · | · | $297M | · | · | · | · | |
| Retained Earnings | $-3M | $-40M | $-41M | $-45M | $-61M | $-155M | $-171M | $-130M | $-65M | $-233.9K | |
| Stockholders' Equity | $300M | $263M | $279M | $266M | $241M | $142M | $52M | $40M | $-15M | $-16M | |
| Liabilities + Equity | $599M | $498M | $460M | $449M | $443M | $290M | $221M | $164M | $149M | $311M | |
| Shares Outstanding | 126,951,876 | 125,730,236 | 131,316,396 | 130,919,129 | 128,680,192 | 127,731,833 | 104,870,886 | 91,261,413 | 66,983,139 | 63,872,058 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $15M | $14M | $10M | $6M | · | · | · | · | · | · | |
| Stock-based Comp | $13M | $11M | $9M | $7M | $4M | $2M | $936.0K | $1M | $919.0K | $473.0K | |
| Deferred Tax | $10M | $-11M | $2M | $2M | $-32M | $112.0K | $111.0K | $186.0K | $-7M | · | |
| Amort. of Intangibles | $3M | $3M | $5M | $5M | $5M | $4M | $6M | $4M | $2M | $2M | |
| Restructuring | $516.0K | $0 | $4M | $2M | $5M | $618.0K | · | · | · | · | |
| Other Non-cash | $-85M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-10M | $14M | $31M | $25M | $62M | $5M | $-34M | $-61M | $-3M | $-5M | |
| CapEx | $14M | $10M | $24M | $34M | $31M | $18M | $6M | $2M | $2M | $1M | |
| Investing Cash Flow | $-14M | $-10M | $-24M | $-34M | $-31M | $-23M | $-6M | $-2M | $-15M | $-1M | |
| Stock Issued | · | · | · | · | · | $65M | $50M | $92M | · | $304M | |
| Stock Repurchased | · | $25M | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $304M | |
| Financing Cash Flow | $-17M | $28M | $-6M | $-2M | $-1M | $42M | $79M | $82M | $19M | $7M | |
| Net Change in Cash | $-42M | $32M | $1M | $-11M | $30M | $24M | $39M | $19M | $500.0K | $659.0K | |
| Taxes Paid | $5M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-24M | · | $7M | $-9M | · | · | · | · | · | · | |
| Levered FCF | · | · | $6M | $-11M | · | · | · | · | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 75.4% | 76.7% | · | · | · | · | · | · | |
| Operating Margin | 7.9% | · | 2.9% | 5.0% | · | · | · | · | · | · | |
| Net Margin | 6.6% | · | 1.1% | 3.4% | · | · | · | · | · | · | |
| Pretax Margin | 8.3% | · | 2.4% | 4.5% | · | · | · | · | · | · | |
| EBITDA Margin | 10.6% | · | 2.9% | 5.0% | · | · | · | · | · | · | |
| ROA | 6.8% | · | 1.1% | 3.5% | · | · | · | · | · | -0.13% | |
| ROE | 13.9% | · | 1.8% | 5.9% | · | · | · | · | · | -4.9% | |
| ROIC | 11.7% | · | 2.1% | 6.4% | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | · | 2.8 | 3.0 | · | · | · | · | · | 3.0 | |
| Quick Ratio | 3.1 | · | 2.3 | 2.6 | · | · | · | · | · | 2.2 | |
| Interest Coverage | · | · | 5.7 | 11.1 | · | · | · | · | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | · | 1.0 | 1.0 | · | · | · | · | · | 0.0 | |
| Inventory Turnover | · | · | 4.0 | 4.2 | · | · | · | · | · | · | |
| Receivables Turnover | 3.4 | · | 5.1 | 5.2 | · | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.36 | · | $2.12 | $2.03 | · | · | · | · | · | $0.54 | |
| Revenue / Share | $4.33 | · | $3.26 | $3.41 | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.08 | · | $0.23 | $0.19 | · | · | · | · | · | · | |
| Cash / Share | $0.74 | · | $0.79 | $0.78 | · | · | · | · | · | $0.11 | |
| EPS (TTM) | $0.15 | $-0.01 | $0.04 | $0.12 | $0.70 | $0.15 | $-0.42 | $-0.94 | $-0.13 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 17.0% | 11.3% | -3.9% | -3.5% | 38.1% | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.8% | 1.0% | 8.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.8% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | -66.7% | -82.9% | 366.7% | · | · | · | · | · | |
| EPS CAGR 3Y | 7.7% | · | -35.6% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 0.00% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 4201.1% | -82.6% | -68.2% | -83.5% | 446.6% | · | · | · | · | · | |
| Net Income CAGR 3Y | 33.6% | -79.1% | -34.0% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 16.5% | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $564M | $482M | $433M | $451M | $467M | $338M | $261M | $193M | $199M | $139M | |
| Net Income TTM | $37M | $861.0K | $5M | $16M | $94M | $17M | $-39M | $-65M | $-8M | $-17M | |
| Market Cap | $658M | · | $537M | $352M | · | · | · | · | · | · | |
| P/E | 34.5 | -320.0 | 102.2 | 22.4 | 13.2 | 50.2 | -11.5 | -10.8 | -76.3 | · | |
| P/S | 1.2 | · | 1.2 | 0.8 | · | · | · | · | · | · | |
| P/B | 2.2 | · | 1.9 | 1.3 | · | · | · | · | · | · | |
| P / Tangible Book | 2.5 | 1.8 | 2.3 | 1.6 | 6.4 | 11.7 | · | · | · | · | |
| P / Cash Flow | -63.8 | · | 17.4 | 14.2 | · | · | · | · | · | · | |
| P / FCF | -26.9 | · | 82.0 | -39.0 | · | · | · | · | · | · | |
| Earnings Yield | 2.9% | -0.31% | 0.98% | 4.5% | 7.6% | 2.0% | -8.7% | -9.3% | -1.3% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44M | $37M | $226M | $151M | $101M | $87M | $127M | $115M | $130M | $110M | $100M | $109M | $117M | $108M | $116M | $117M | |
| Cost of Revenue | · | · | · | · | · | $24M | · | $27M | $29M | $29M | · | $26M | $26M | $27M | $27M | $26M | |
| Gross Profit | · | · | · | · | · | $63M | · | $88M | $101M | $81M | · | $83M | $91M | $81M | $88M | $91M | |
| R&D Expense | $18M | $15M | $10M | $13M | $10M | $11M | $12M | $10M | $16M | $13M | $12M | $10M | $11M | $11M | $11M | $10M | |
| SG&A Expense | $54M | $65M | $100M | $80M | $74M | $73M | $74M | $72M | $77M | $72M | $61M | $64M | $70M | $74M | $68M | $79M | |
| Operating Expenses | $95M | $106M | $186M | $130M | $114M | $113M | $145M | $109M | $144M | $85M | $180M | $75M | $81M | $85M | $80M | $89M | |
| Operating Income | $-51M | $-69M | $63M | $21M | $-13M | $-27M | $10M | $6M | $-14M | $-4M | $-1M | $8M | $10M | $-4M | $9M | $2M | |
| Interest Expense | · | · | · | · | · | · | · | · | $620.0K | $514.0K | · | $444.0K | $594.0K | $649.0K | · | $572.0K | |
| Other Non-op | $-26.0K | $38.0K | $-98.0K | $18.0K | $73.0K | $2.0K | $-27.0K | $52.0K | $-28.0K | $23.0K | $-25.0K | $31.0K | $28.0K | $23.0K | $6.0K | $5.0K | |
| Pretax Income | $-51M | $-68M | $63M | $21M | $-12M | $-26M | $10M | $6M | $-15M | $-4M | $-2M | $8M | $9M | $-5M | $9M | $1M | |
| Income Tax | $45M | $-15M | $20M | $-407.0K | $-2M | $-7M | $3M | $-7M | $3M | $-2M | $-1M | $4M | $4M | $-2M | $1M | $997.0K | |
| Net Income | $-96M | $-53M | $44M | $22M | $-9M | $-19M | $8M | $12M | $-17M | $-2M | $-569.0K | $3M | $5M | $-3M | $7M | $215.0K | |
| EPS (Basic) | $-0.77 | $-0.44 | $0.32 | $0.11 | $-0.10 | $-0.17 | $0.05 | $0.09 | $-0.13 | $-0.02 | $0.00 | $0.02 | $0.04 | $-0.02 | $0.06 | $0.00 | |
| EPS (Diluted) | $-0.77 | $-0.44 | $0.31 | $0.11 | $-0.10 | $-0.17 | $0.05 | $0.09 | $-0.13 | $-0.02 | $0.00 | $0.02 | $0.04 | $-0.02 | $0.06 | $0.00 | |
| Shares (Basic) | 128,674,548 | 127,797,013 | · | 126,881,709 | 126,853,536 | 126,295,642 | · | 132,575,301 | 132,573,153 | 131,861,772 | · | 131,312,483 | 131,293,398 | 131,083,841 | · | 130,903,160 | |
| Shares (Diluted) | 128,674,548 | 127,797,013 | · | 130,848,995 | 126,853,536 | 126,295,642 | · | 133,926,755 | 132,573,153 | 131,861,772 | · | 133,417,721 | 133,066,010 | 131,083,841 | · | 132,232,954 | |
| EBITDA | $-51M | $-65M | · | $21M | $-13M | $-23M | · | $10M | $-11M | $-4M | · | $8M | $10M | $-4M | · | $2M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $91M | $94M | $64M | $73M | $110M | $136M | $94M | $90M | $89M | · | $98M | $89M | $89M | · | $107M | |
| Receivables | $101M | $117M | $217M | $169M | $120M | $103M | $110M | $101M | $106M | $96M | · | $89M | $94M | $92M | · | $93M | |
| Inventory | $29M | $28M | $30M | $40M | $33M | $29M | $26M | $27M | $27M | $28M | · | $28M | $25M | $26M | · | $25M | |
| Prepaid Expense | $20M | $29M | $18M | $23M | $28M | $18M | $14M | $15M | $11M | $14M | · | $10M | $8M | $10M | · | $5M | |
| Current Assets | $200M | $269M | $362M | $300M | $260M | $268M | $286M | $239M | $234M | $227M | · | $226M | $216M | $217M | · | $231M | |
| PP&E (Net) | $102M | $104M | $104M | $78M | $76M | $76M | $89M | $90M | $90M | $114M | · | $118M | $112M | $107M | · | $97M | |
| PP&E (Gross) | · | · | $165M | $135M | $132M | $128M | $140M | $144M | $146M | $131M | · | $128M | $119M | $116M | · | $99M | |
| Accum. Depreciation | · | · | $88M | $84M | $80M | $76M | $73M | $75M | $75M | $75M | · | $70M | $68M | $65M | · | $62M | |
| Goodwill | $29M | $29M | $29M | $29M | $29M | $29M | $29M | $29M | $29M | $29M | · | $29M | $29M | $29M | · | $29M | |
| Intangibles | $3M | $3M | $9M | $10M | $11M | $12M | $12M | $13M | $14M | $15M | · | $17M | $18M | $20M | · | $22M | |
| Other Non-current Assets | $23M | $16M | $9M | $14M | $9M | $6M | $5M | $5M | $6M | $7M | · | $1M | $1M | $1M | · | $2M | |
| Total Assets | $406M | $520M | $599M | $510M | $461M | $467M | $498M | $446M | $443M | $458M | · | $463M | $450M | $446M | · | $457M | |
| Accounts Payable | $29M | $29M | $32M | $40M | $30M | $25M | $29M | $24M | $29M | $23M | · | $27M | $27M | $30M | · | $38M | |
| Accrued Liabilities | · | · | $50M | $40M | $26M | $31M | $39M | $36M | $38M | $40M | · | $35M | $28M | $29M | · | $34M | |
| Current Liabilities | $57M | $76M | $100M | $90M | $66M | $65M | $77M | $77M | $86M | $83M | · | $81M | $73M | $76M | · | $89M | |
| Capital Leases | $21M | $22M | $22M | $24M | $25M | $26M | $25M | $23M | $23M | $24M | · | $39M | $40M | $40M | · | $43M | |
| Other Non-current Liabilities | $4M | $1M | $1M | $3M | $3M | $897.0K | $894.0K | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Total Liabilities | $118M | $139M | $165M | $124M | $100M | $99M | $113M | $168M | $180M | $180M | · | $186M | $179M | $182M | · | $201M | |
| Long-term Debt | · | · | · | · | · | · | · | $62M | $64M | $65M | · | $68M | $69M | $70M | · | $73M | |
| Common Stock | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | · | $13.0K | $13.0K | $13.0K | · | $13.0K | |
| Retained Earnings | $-153M | $-56M | $-3M | $-47M | $-68M | $-59M | $-40M | $-48M | $-60M | $-43M | · | $-40M | $-44M | $-49M | · | $-53M | |
| Stockholders' Equity | $148M | $245M | $300M | $255M | $233M | $243M | $263M | $279M | $264M | $278M | $279M | $277M | $271M | $264M | $266M | $256M | |
| Liabilities + Equity | $406M | $520M | $599M | $510M | $461M | $467M | $498M | $446M | $443M | $458M | · | $463M | $450M | $446M | · | $457M | |
| Shares Outstanding | 128,674,548 | 128,674,548 | 126,951,876 | 126,911,442 | 126,853,536 | 126,853,536 | 125,730,236 | 132,576,502 | 132,574,238 | 132,539,340 | 131,316,396 | 131,312,616 | 131,311,852 | 131,226,387 | 130,919,129 | 130,915,099 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $4M | $4M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | · | · | · | |
| Stock-based Comp | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Deferred Tax | $45M | $-15M | $16M | $-4M | $-1M | $-1M | $-3M | $-2M | · | · | $2M | · | · | · | · | · | |
| Amort. of Intangibles | $433.0K | $6M | $798.0K | $842.0K | $841.0K | $842.0K | $834.0K | $834.0K | $834.0K | $901.0K | $1M | $1M | $1M | $1M | $1M | $1M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $2M | $96.0K | $-126.0K | $2M | $750.0K | $611.0K | |
| Other Non-cash | · | $82M | · | · | · | $-7M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-32M | $21M | $39M | $3M | $-33M | $-20M | $11M | $9M | $5M | $-10M | $11M | $17M | $9M | $-5M | $8M | $5M | |
| CapEx | $1M | $3M | $5M | $2M | $4M | $4M | $3M | $3M | $2M | $2M | $3M | $6M | $7M | $8M | $11M | $10M | |
| Investing Cash Flow | $-1M | $-3M | $-5M | $-2M | $-4M | $-4M | $-3M | $-3M | $-2M | $-2M | $-3M | $-6M | $-7M | $-8M | $-11M | $-10M | |
| Financing Cash Flow | $-13M | $-20M | $-5M | $-10M | $-288.0K | $-2M | $34M | $-2M | $-2M | $-3M | $-2M | $-1M | $-1M | $-1M | $-2M | $26.0K | |
| Net Change in Cash | $-45M | $-2M | $30M | $-9M | $-37M | $-26M | $41M | $4M | $1M | $-15M | $6M | $9M | $93.0K | $-14M | $-5M | $-5M | |
| Free Cash Flow | · | $18M | · | · | · | $-24M | · | · | · | $-12M | · | · | · | $-13M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-13M | · | · | · | $-13M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 72.6% | · | 76.7% | 77.6% | 73.9% | · | 76.2% | 77.6% | 75.3% | · | 77.6% | |
| Operating Margin | -116.5% | -185.1% | · | 13.7% | -12.4% | -30.9% | · | 5.4% | -10.7% | -3.5% | · | 7.4% | 8.3% | -3.7% | · | 1.5% | |
| Net Margin | -220.0% | -142.8% | · | 14.3% | -9.3% | -21.7% | · | 10.7% | -13.1% | -1.9% | · | 2.9% | 4.5% | -2.8% | · | 0.18% | |
| Pretax Margin | -116.3% | -183.9% | · | 14.0% | -11.7% | -29.7% | · | 5.1% | -11.2% | -4.0% | · | 7.0% | 7.8% | -4.3% | · | 1.0% | |
| EBITDA Margin | -116.5% | -173.8% | · | 13.7% | -12.4% | -26.9% | · | 8.5% | -8.1% | -3.5% | · | 7.4% | 8.3% | -3.7% | · | 1.5% | |
| ROA | -22.2% | -10.8% | · | 4.5% | -2.1% | -4.1% | · | 2.7% | -3.8% | -0.46% | · | 0.69% | 1.2% | -0.67% | · | 0.05% | |
| ROE | -50.5% | -21.8% | · | 8.1% | -3.8% | -7.2% | · | 4.4% | -6.4% | -0.78% | · | 1.2% | 2.0% | -1.2% | · | 0.10% | |
| ROIC | -65.1% | -21.9% | · | 8.3% | -4.3% | -8.1% | · | 4.8% | -6.2% | -0.67% | · | 1.2% | 2.1% | -0.97% | · | 0.12% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 3.5 | · | 3.3 | 4.0 | 4.1 | · | 3.1 | 2.7 | 2.7 | · | 2.8 | 2.9 | 2.9 | · | 2.6 | |
| Quick Ratio | 2.6 | 2.7 | · | 2.6 | 2.9 | 3.3 | · | 2.5 | 2.3 | 2.2 | · | 2.3 | 2.5 | 2.4 | · | 2.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -22.4 | -7.5 | · | 18.1 | 16.4 | -6.2 | · | 3.1 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.3 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.3 | 0.2 | · | 0.3 | |
| Inventory Turnover | · | · | · | · | · | 0.8 | · | 1.0 | 1.1 | 1.1 | · | 1.0 | 1.1 | 1.1 | · | 1.0 | |
| Receivables Turnover | 0.4 | 0.3 | · | 1.1 | 0.9 | 0.9 | · | 1.2 | 1.3 | 1.2 | · | 1.2 | 1.3 | 1.3 | · | 1.4 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.15 | $1.90 | · | $2.01 | $1.84 | $1.91 | · | $2.10 | $1.99 | $2.10 | · | $2.11 | $2.07 | $2.01 | · | $1.96 | |
| Revenue / Share | $0.34 | $0.29 | · | $1.15 | $0.80 | $0.69 | · | $0.86 | $0.98 | $0.83 | · | $0.81 | $0.88 | $0.82 | · | $0.88 | |
| Cash Flow / Share | · | $0.17 | · | · | · | $-0.16 | · | · | · | $-0.08 | · | · | · | $-0.04 | · | · | |
| Cash / Share | $0.36 | $0.71 | · | $0.50 | $0.58 | $0.87 | · | $0.71 | $0.68 | $0.67 | · | $0.75 | $0.68 | $0.68 | · | $0.82 | |
| EPS (TTM) | $-0.79 | $-0.12 | · | $-0.11 | $-0.13 | $-0.16 | · | $-0.06 | $-0.13 | $0.04 | · | $0.10 | $0.08 | $0.11 | · | $0.45 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $457M | $515M | · | $465M | $430M | $459M | · | $455M | $448M | $435M | · | $449M | $457M | $461M | · | $463M | |
| Net Income TTM | $-84M | $3M | · | $1M | $-8M | $-16M | · | $-7M | $-17M | $6M | · | $13M | $10M | $13M | · | $59M | |
| Market Cap | $313M | $305M | · | $536M | $464M | $548M | · | $379M | $371M | $376M | · | $418M | $436M | $280M | · | $424M | |
| P/E | -3.1 | -19.8 | · | -38.4 | -28.2 | -27.0 | · | -47.7 | -21.5 | 71.0 | · | 31.8 | 41.5 | 19.4 | · | 7.2 | |
| P/S | 0.7 | 0.6 | · | 1.2 | 1.1 | 1.2 | · | 0.8 | 0.8 | 0.9 | · | 0.9 | 1.0 | 0.6 | · | 0.9 | |
| P/B | 2.1 | 1.2 | · | 2.1 | 2.0 | 2.3 | · | 1.4 | 1.4 | 1.4 | · | 1.5 | 1.6 | 1.1 | · | 1.7 | |
| P / Tangible Book | 2.7 | 1.4 | · | 2.5 | 2.4 | 2.7 | · | 1.6 | 1.7 | 1.6 | · | 1.8 | 1.9 | 1.3 | · | 2.1 | |
| P / Cash Flow | · | 14.4 | · | · | · | -27.5 | · | · | · | -37.0 | · | · | · | -55.1 | · | · | |
| Earnings Yield | -32.5% | -5.1% | · | -2.6% | -3.5% | -3.7% | · | -2.1% | -4.6% | 1.4% | · | 3.1% | 2.4% | 5.2% | · | 13.9% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $564M | $482M | $433M | $451M | $467M |
| Bruttogewinnmarge % | · | · | 75.4% | 76.7% | · |
| Betriebsgewinnmarge % | 7.9% | · | 2.9% | 5.0% | · |
| Nettoergebnis | $37M | $861.0K | $5M | $16M | $94M |
| Verwässerte EPS | $0.15 | $-0.01 | $0.04 | $0.12 | $0.70 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 3.6 | · | 2.8 | 3.0 | · |
| Quick Ratio | 3.1 | · | 2.3 | 2.6 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-24M | · | $7M | $-9M | · |
Institutionelle Eigentümer (13F) 140 Einreicher · $179.8M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
140
Gehaltener Wert
$179.8M
Neue Positionen
32
Geschlossene Positionen
14
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 32 (+14 vs. Vorquartal) | 14 (-26 vs. Vorquartal) | 52 (+20 vs. Vorquartal) | 33 (-13 vs. Vorquartal) | +4.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| MORGAN STANLEY | $28.483.510 | 11.721.609 | 15,84% | Aktien |
| VANGUARD GROUP INC | $25.686.978 | 4.958.876 | 14,28% | Aktien |
| Soleus Capital Management, L.P. | $24.642.511 | 10.140.951 | 13,70% | Aktien |
| BlackRock, Inc. | $17.616.354 | 7.249.528 | 9,80% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $7.412.123 | 3.050.297 | 4,12% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $7.318.559 | 3.011.753 | 4,07% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $7.061.383 | 2.905.919 | 3,93% | Aktien |
| D. E. Shaw & Co., Inc. | $7.018.601 | 2.888.313 | 3,90% | Aktien |
| Assenagon Asset Management S.A. | $4.782.123 | 1.967.952 | 2,66% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $4.704.612 | 1.935.554 | 2,62% | Aktien |
| DEUTSCHE BANK AG\ | $4.146.032 | 1.706.186 | 2,31% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3.906.781 | 1.607.729 | 2,17% | Aktien |
| STATE STREET CORP | $3.693.491 | 1.519.955 | 2,05% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $2.471.585 | 1.017.113 | 1,37% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.199.208 | 905.024 | 1,22% | Aktien |
| GOLDMAN SACHS GROUP INC | $2.156.380 | 887.399 | 1,20% | Aktien |
| CITADEL ADVISORS LLC | $2.109.067 | 867.929 | 1,17% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1.682.039 | 692.197 | 0,94% | Aktien |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $1.527.741 | 628.700 | 0,85% | Aktien |
| NORTHERN TRUST CORP | $1.420.522 | 584.577 | 0,79% | Aktien |
| BANK OF AMERICA CORP /DE/ | $1.368.206 | 563.048 | 0,76% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $1.336.500 | 550.000 | 0,74% | Aktien |
| NORGES BANK | $1.290.087 | 530.900 | 0,72% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.203.732 | 495.363 | 0,67% | Aktien |
| FLAX POND CAPITAL, LLC | $1.026.896 | 422.591 | 0,57% | Aktien |
| UBS Group AG | $871.661 | 358.708 | 0,48% | Aktien |
| Bank of New York Mellon Corp | $776.732 | 319.643 | 0,43% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $755.154 | 310.763 | 0,42% | Aktien |
| Squarepoint Ops LLC | $613.881 | 252.626 | 0,34% | Aktien |
| ExodusPoint Capital Management, LP | $556.067 | 228.834 | 0,31% | Aktien |
| FMR LLC | $523.944 | 215.615 | 0,29% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $498.667 | 205.213 | 0,28% | Aktien |
| Nuveen, LLC | $469.488 | 193.205 | 0,26% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $454.354 | 186.977 | 0,25% | Aktien |
| XTX Topco Ltd | $446.537 | 183.760 | 0,25% | Aktien |
| Vanguard Global Advisers, LLC | $419.586 | 172.669 | 0,23% | Aktien |
| Invesco Ltd. | $410.437 | 168.904 | 0,23% | Aktien |
| BARCLAYS PLC | $394.780 | 162.461 | 0,22% | Aktien |
| Wealth Dimensions Group, Ltd. | $369.968 | 152.250 | 0,21% | Aktien |
| Mariner, LLC | $358.977 | 147.731 | 0,20% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $351.769 | 144.761 | 0,20% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $351.518 | 148.320 | 0,20% | Aktien |
| HSBC HOLDINGS PLC | $323.561 | 139.166 | 0,18% | Aktien |
| Cerity Partners LLC | $310.018 | 127.579 | 0,17% | Aktien |
| AMERIPRISE FINANCIAL INC | $239.445 | 98.537 | 0,13% | Aktien |
| RHUMBLINE ADVISERS | $208.147 | 85.660 | 0,12% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $205.943 | 84.750 | 0,11% | Aktien |
| Creative Planning | $205.160 | 84.428 | 0,11% | Aktien |
| State of Wyoming | $203.738 | 83.843 | 0,11% | Aktien |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $181.577 | 75.657 | 0,10% | Aktien |
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Glenn H. Nussdorf, GN 2016 Family Trust u/a/d August 12, 2016, GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 | 3. November 2025 | 9,70% | Änderung | · | SEC |
| Alan A. Ades, Albert Erani, Glenn H. Nussdorf, Dennis Erani, Starr Wisdom, Organo PFG LLC, Organo Investors LLC, Alan Ades 2014 GRAT, Albert Erani Family Trust dated 12/29/2012, Dennis Erani 2012 Issue Trust dated 12/20/12, GN 2016 Family Trust u/a/d August 12, 2016, GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016, RED Holdings, LLC, Josette Ades ×11 Einreichungen | 26. Juni 2025 | 17,60% | Änderung | · | SEC |
| Avista Healthcare Partners III, L.P., AHP III Orchestra Holdings, L.P., Avista Capital Partners VI GP, L.P., Avista Capital Managing Member VI, LLC, Thompson Dean, David Burgstahler | 19. November 2024 | · | Erste Einreichung | Passive Anlage | SEC |
| Avista Acquisition Corp., Avista Acquisition, LLC, Avista Capital Partners (Offshore) IV, LP, Avista Capital Partners IV, L.P., Avista Capital Managing Member IV, LLC, Avista Capital Partners IV GP L.P., Thompson Dean, David Burgstahler ×6 Einreichungen | 27. Mai 2021 | · | Erste Einreichung | · | SEC |
| Avista Acquisition Corp. (2), Avista Acquisition, LLC. (2), Avista Capital Partners (Offshore) IV, LP (2), Avista Capital Partners IV, L.P. (2), Avista Capital Managing Member IV, LLC (2), Avista Capital Partners, IV GP L.P. (2), Thompson Dean (2), David Burgstahler (2) | 20. Dezember 2018 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 27 Insider · 10 Führungskräfte · 15 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Gary S. Gillheeney | President and CEO | 18. Februar 2026 F | 4.232.087 | 0 | 0 | $0 |
| David Francisco | Chief Financial Officer | 18. Februar 2026 F | 731.312 | 0 | 0 | $0 |
| Henry Hagopian III | Interim CFO | 13. Januar 2021 A | 12.073 | 0 | 0 | $0 |
| Timothy M. Cunningham | Chief Financial Officer | 22. April 2020 A | 27.847 | 0 | 0 | $0 |
| Patrick Bilbo | Chief Operating Officer | 18. Februar 2026 F | 1.128.312 | 0 | 0 | $0 |
| Robert Cavorsi | Vice President, Strategy | 1. März 2026 F | 275.524 | 0 | 0 | $0 |
| Antonio S. Montecalvo | Vice President, Health Policy | 18. Februar 2026 F | 226.238 | 0 | 0 | $0 |
| Lori Freedman | Chief Admin. and Legal Officer | 18. Februar 2026 F | 1.023.643 | 0 | 0 | $0 |
| Brian Grow | Chief Commercial Officer | 10. Januar 2025 M | 900.682 | 0 | 0 | $0 |
| Howard Walthall | Exec. VP, Strat. & Mkt Dev. | 10. Dezember 2018 A | · | 0 | 0 | $0 |
| Michael Joseph Driscoll | Direktor | 9. März 2026 P | 225.707 | 1 | 0 | $26.700 |
| Arthur S Leibowitz | Direktor | 9. März 2026 P | 291.014 | 1 | 0 | $13.400 |
| Garrett Lustig | Direktor | 18. Februar 2026 A | 125.742 | 0 | 0 | $0 |
| Gilberto Quintero | Direktor | 18. Februar 2026 A | 239.073 | 0 | 0 | $0 |
| Prathyusha Duraibabu | Direktor | 18. Februar 2026 A | 247.047 | 0 | 0 | $0 |
| Michele Ilene Korfin | Direktor | 18. Februar 2026 A | 239.073 | 0 | 0 | $0 |
| Jon L Giacomin | Direktor | 18. Februar 2026 A | 241.026 | 0 | 0 | $0 |
| Glenn H. Nussdorf | Direktor | 16. Dezember 2025 S | 2.565.591 | 2 | 6 | $-1.603.954 |
| Joshua Alexander Tamaroff | Direktor | 16. Februar 2021 A | 30.364 | 0 | 0 | $0 |
| Wayne D Mackie | Direktor | 16. Februar 2021 A | 211.800 | 0 | 0 | $0 |
| Robert P O'Neil | Direktor | 10. Dezember 2018 D | · | 0 | 0 | $0 |
| Charles C Harwood Jr | Direktor | 10. Dezember 2018 D | · | 0 | 0 | $0 |
| Hakan Bjorklund | Direktor | 10. Dezember 2018 D | · | 0 | 0 | $0 |
| Brian A Markison | Direktor | 10. Dezember 2018 D | · | 0 | 0 | $0 |
| Michael W Katz | 10%-Eigentümer | 21. November 2022 P | 76.382 | 0 | 0 | $0 |
| Dennis Erani | 10%-Eigentümer | 27. Mai 2021 S | 1.314.517 | 0 | 0 | $0 |
| Starr Wisdom | 10%-Eigentümer | 9. April 2021 S | 20.000 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 22 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| VFQY · VANGUARD WELLINGTON FUND | 0,03% | 49.635 SH | 19. August 2026 | Täglich |
| IWC · iShares Trust | 0,03% | 239.111 SH | 11. September 2026 | Täglich |
| VFVA · VANGUARD WELLINGTON FUND | 0,02% | 79.308 SH | 19. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 396.742 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 60.177 SH | 19. August 2026 | Täglich |
| DFSV · Dimensional ETF Trust | 0,01% | 267.878 NS | 31. Juli 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 129.858 SH | 2. Oktober 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 33.027 NS | 31. Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 295.905 NS | 31. Juli 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,00% | 221.009 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 1.771.226 SH | 11. September 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,00% | 4.647 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 205.812 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 9.772 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 22.383 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 31.880 SH | 9. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 9.630 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 848.524 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.991.446 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.493 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,00% | 189.815 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 625.359 SH | 11. September 2026 | Täglich |
ORGO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 7 Analysten
VERKAUF
Median-Ziel
$2.00
+50,4%
0 0,0%
Starker Kauf
0 0,0%
Kauf
4 57,1%
Halten
1 14,3%
Verkauf
2 28,6%
Starker Verkauf
12-Monats-Kursziel
1 Analysten · 2026-09-20Mittelwert-Ziel $2.00 +50,4%
Tief$2.00
Mittelwert$2.00
Hoch$2.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | · |
| CNTN | $112M | -2.7 | · | · | -18.0% | · |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | · |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | · |
| ALXO | $61M | -0.6 | · | · | -225.0% | · |
| AVXL | · | -16.5 | -36.1% | -991.4% | · | · |
| VYGR | $232M | -1.9 | -49.5% | -296.5% | -54.4% | · |
| TARA | $286M | -4.0 | · | · | -33.7% | · |
| PEPG | $448M | -3.1 | · | · | -82.0% | · |
| NERV | $174M | -0.1 | · | · | 339.5% | · |
| CMPX | $958M | · | · | · | -45.9% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026